En poursuivant la navigation sur ce site vous acceptez l'utilisation des cookies.
XMEDLINE via PubMed
http://www.ncbi.nlm.nih.gov/pubmed
Cochrane Library
http://www.thecochranelibrary.com
Declaration d'Helsinki
http://www.wma.net/en/30publications/10policies/b3/index.html
ISO 14155:2011, Clinical investigation of medical devices for human subjects – Good Clinical Practice
http://www.iso.org/iso/catalogue_detail?csnumber=45557
Good Clinical Practice and other ICH guidelines for clinical trials:
http://www.ich.org/products/guidelines/efficacy/article/general-principle-on-planningdesigning-multi-regional-clinical-trials.html
http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf
Centre for Evidence-Based Medicine, Oxford, UK
www.cebm.net
The Equator-network resource center for improved reporting of health research studies
http://www.equator-network.org/
The PRISMA statement, i.e. Preferred Reporting Items for Systematic Reviews and Meta-Analyses, is a minimum set of items for reporting systematic reviews and meta-analyses
http://www.prisma-statement.org/
The CONSORT statement, i.e. Consolidated Standards of Reporting Trials, is a minimum set of recommendations for reporting randomized trials
http://www.consort-statement.org/
The STROBE statement, i.e. Strengthening the Reporting of Observational studies in Epidemiology, is a checklist of items that should be included in articles reporting observational studies
http://www.strobe-statement.org/
Suivez-nous sur :
A propos de nous
Information légale
Wellspect HealthCare
Dentsply Sirona (Schweiz) AG
Täfernweg 1
5405 Baden-Dättwil
SCHWEIZ
TELEFON +41 (0) 800 620 240
TELEFAX +41 (0) 800 620 241
info-ch@wellspect.com
http://fr.wellspect.ch/
Contactez le siège mondial ou une filiale / un distributeur dans un autre pays
©2021 Wellspect HealthCare, a Dentsply Sirona Company. All rights reserved.